The Potential for Clinical Dependence and Withdrawal Symptoms Associated With Valbenazine

Phase 4 Completed 89 enrolled Neurocrine Biosciences

RandomizedParallel-groupTriple-blindTreatment

Summary

This is a Phase 4, randomized, double-blind, placebo-controlled study to evaluate the potential for clinical dependence and withdrawal symptoms associated with valbenazine.

Timeline

Start: 2018-09-14
Primary completion: 2019-04-03
Completion: 2019-04-03

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Valbenazine	Small molecule	—	Oral

The Potential for Clinical Dependence and Withdrawal Symptoms Associated With Valbenazine

Summary

Timeline

Drugs

Indications